CalciMedica Inc
Veridion Score
Composite trend over time
Why is CALC moving today?
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CALC.
CALC insider activity
CalciMedica Inc
No multi-insider buying cluster in the last 90 days
Net buying: $253K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-22 | 2025-09-18 | Roberts Eric W | Insider | buy | $3.07 | 2,500 | 84,150 | $8K | SEC Form 4 |
| 2025-09-17 | 2025-09-15 | Roberts Eric W | Insider | buy | $2.68 | 3,400 | 81,650 | $9K | SEC Form 4 |
| 2025-09-15 | 2025-09-12 | Roberts Eric W | Insider | buy | $3.12 | 5,000 | 78,250 | $16K | SEC Form 4 |
| 2025-09-11 | 2025-09-09 | Roberts Eric W | Insider | buy | $3.15 | 2,343 | 73,250 | $7K | SEC Form 4 |
| 2025-09-02 | 2025-08-29 | Roberts Eric W | Insider | buy | $2.74 | 800 | 70,907 | $2K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 20 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCALC contract awards, year to date.
Public federal awards linked to this ticker.
CALC lobbying filings, year to date.
Registered lobbying filings matched to CalciMedica Inc.